Abstract: Spinal cord injuries (SCI) are very traumatic to the body; they can lead to permanent loss of motor and sensation. The injury also causes inflammation and the formation of glial scars, which inhibit neurite growth. It is thus very difficult to treat SCI's due to the inhospitable environment at and around the lesion site. This paper explores hydrogels as a desired tool for treating SCI's due to their ability to mimic the structure of the extracellular matrix (ECM), which supports cells and promotes their proliferation migration differentiation, as well as their ability to guide implanting neural tissue to restore and replace damaged tissue. The implantation of cells and molecules via hydrogels is promising and has been explored for SCI regeneration.
Introduction
Spinal cord injuries (SCI), which lead to permanent motor and sensory deficits below their lesion site, are among the most challenging injuries to treat in clinics. Many treatments have been explored, but they remain ineffective (1) . Primary spinal cord injuries result in secondary damages that include edema, vasospasm, excitotoxicity, inflammation, free radical production, ischemia, and demyelination (2) . These secondary damages lead to the loss of neurons and glial scar formation (3) , which leads to the creation of an impermeable barrier that axons cannot regenerate across (4) . The Central Nerve System (CNS) has limited capabilities for axon regeneration, requiring the removal of scar tissue and the reconstruction of the injury site with glial cells, mesenchymal, blood vessels, extracellular matrix (ECM) and nervefibers (5, 6) . Cell-based and molecule-based treatment strategies are a hopeful future cure for SCIs. However, traditional administrations, such as oral and intravenous, are limited by the blood-brain barrier (BBB) and blood cerebrospinal fluid barrier (BCSFB). Low diffusion makes these conventional methods ineffective (6, 7) . Furthermore, an ideal delivery system to achieve local and sustained delivery of cells and molecules is needed.Hydrogels are a promising alternative because they have properties that mimic the ECM to provide substrates for neurons' adhesion proliferation and differentiation. This review will highlight the advantages of hydrogels applied to cell-based and molecule-based treatment strategies for SCI.
Current methods of delivery

Oral and intravenous administration
The blood-brain barrier (BBB) and blood cerebrospinal fluid barrier (BCSFB) protect the central nerve sys-and molecules. After transplantation, grafted cells and molecules maintain their own bioactivity to ensure successful regeneration of tissue. Representative example is poly(vinyl alcohol) hydrogel(PVA-H) (13) . Stability: Materials are stable enough to avoid dispersing by environmental elements, such as temperature and power of hydrogen (PH). This stability provides long-term support for tissue regeneration. It is necessary that these materials are capable of protecting encapsulated cells and molecules under mild conditions to make sure that the cells and molecules are delivered to the lesion site. Won et al. add a small quantity of graphene oxide to Pluronic copolymers to enhance stability of Pluronic gel (14) . Degradation: Implantation materials must be degradable or their residue may cause immune response or inflammation at the lesion site. Unwanted byproducts may also swell and lead to compression of the spinal cord. Materials must therefore degrade without producing undesired byproducts. There must also be no chemical activations that degrade damaging host or grafted tissue. The rate of degradation must also be regulated; Degradation of materials should be slow enough to allow neuron growth differentiation or the production of neurophic factors with the help of materials. If degradation occurs too quickly, there may not be adequate time for regeneration and the spinal cord may be compressed. If degradation occurs too slowly, on the other hand, the materials may increase the risks of immune response and inhibit the growth of neurons. Degradation of materials should be controlled and adjustable (15) . Jiang et al. demonstrated that after being implanted, poly(ethylene glycol)-grafted-chitosan (PEG-g-CS) hydrogel maintains its integrity for two weeks and in the third week, collapses, merging into the tissue (16) . No cell toxicity: Materials used for transplantation to the spinal cord should be safe for injection and should not harm the host tissue or other organs. These materials should be tested before transplantation to meet safety requirements. This requires material, as well as their additives, to be purified and ensured to be safe for encapsulated cells and molecules . There should be no toxic reactions between materials and their additives. Gupta et al. explored crosslinked pullulan nanoparticles encapsulating bioactive molecules for drug and gene delivery.Cell adhesion/viability assay demonstrated that the pullulan nanoparticles are non-toxic to cells and do not cause any distinct harm to cells (17) . Efficiency: Materials should be designed to have desired outcomes with low concentration.A high concentration of materials may lead to spinal cord compression due to the limited capacity of CNS and also increase the risks of side infections. Li et al. found a thermosensitive hydrogel which could improve the matrix modulus-induced cardiac differentiation efficiency of human mesenchymal stem cells (18) . Bioactivity: Bioactivity of biomaterials can be determined by various factors including porosity, mechanical properties and other soluble and insoluble cues.The proper size of biomaterial nanopores are important for cells' growth, migration and diffusion of bioactive molecules. The 3-dimensional (3D) structure of these pores can mimic the ECM and provide growth-permissive substrates for cells' interactions, which determine cells' survival and growth. The mechanical properties of biomaterial should be similar to those of the host tissue, which gives the materials the structure needed to bear the forces of the surrounding tissue. It is known that the stiffness of biomaterials has an effect on cells' behavior (15) . Lawen Flynn et al. demonstrated that size and arrangement of polycaprolactone (PCL) fibers dispersed in poly (2-hydroxyethyl methacrylate)( pHEMA) gels can control the diameter and number of hydrogel pores. These pores provide bridging support and contacting guidance for neurons (19) .Peter Krsko et al. engineered surfaces that can control ascension and growth of cells and cell processes by controlling hydrogel patterns such as lines and arrays. Furthermore, the spaces between the individual hydrogels determine the adhesion of different kinds of cell populations (20) . In conclusion, pores and channels give biomaterials the ability to enable axon regeneration after SCI by influencing cells' adhesion, growth and other processes. Furthermore,electrospun nanofibers can not only mimick ECM by porosity but also by nanoscale morphology,high surface area and fibrous morphology. Malkoc et al. designed a microdevice on a collagen coated gelatin/PCL nanofiber mat which promote neuron-like PC12 cells' adhesion, differentiation, and neurite outgrowth compared to controls. Malkoc et al. demonstrated that electrospun nanofibers promote neurite outgrowth, produce nanofiber based nerve guidance conduits and provide mechanical and biochemical cues to stimulate stem cells differentiate into progeny (21, 22) .
Introduction of hydrogels
Hydrogels are natural or synthetic water-content polymer networks that can be designed to be biodegradable and release molecules at a controlled rate though cross-link modification (23) . Hydrogels hold great promise as desirable carriers for cell and molecule delivery. They are promising biomaterials in regeneration medicine. Hydrogels have been explored for decades for tissue engineering and have been applied to SCI, which is one of the most complex diseases due to the multiple growth inhibition and difficulties of replacing damaged tissue it causes. Moreover, hydrogels can mimic the native ECM structure (15, 24) . The structure and properties of engineered hydrogels allow localized cell-mediated regeneration that enable cells' survival, spreading and migration (24, 25) . Hydrogel-based delivery systems can also be designed to influence cells' processes. The ability of hydrogels in histocompatibility between host tissue and grafted tissue contributes to tissue regeneration. The future application of hydrogels demand easy synthesis, stability, safety and efficacy.
Hydrogels were first described as a colloidal gel, then reported as water-swollen cross-linked networks. The first generation of hydrogels had a simple network structure that gave hydrogels basic properties such as solute diffusivity and cross-link density. Representative first generation hydrogels are PHEMA, poly vinyl alcohol (PVA) and polyethylene glycol (PEG). Compared with first generation hydrogels , second generation pays attention to the abilities of hydrogels to respond to changes in environment. These environmental changes trigger hydrogels' special events ( i.e gel formation or molecule release). Temperature and PH sensitive hydrogels were then created by modification of hydrophobic interactions and hydrogen bonding (26, 27) . The third generation was further designed to have ability to tune mechanical, thermal and degradable properties. Currently, the most advanced hydrogels are "smart hydrogels", which have proper-ties such as mechanical stability and release kinetics to achieve desired delivery (28) . Hydrogels can be modified by both physical and chemical cross-linkers. Each type of cross-linked hydrogels have their own advantages and disadvantages. Chemically cross-linked hydrogels can survive for long term periods, but demand the fast formation of covalent bonds to get rid of elimination. The hydrogels also should have no cytotoxic agents. On the other hand, physical cross-linked hydrogels appear to be sensitive to environmental stimulations (temperature and PH). The lack of covalent bonds in this hydrogel also makes it easier to eliminate after injection. A high concentration is require, which leads to high osmatic pressure compression of spinal cord. Combined cross-linked strategies also show great promise for tissue regeneration (29) . For example, Malgsia M et al. designed a physical and chemical cross-linked hydrogel xylene monochloride (XMC), which is injectable and is also long-lasting and safe to achieve minimally invasive surgeries and sustained biomolecule delivery (29) .
Ways to measure properties of hydrogels
There are various ways to measure different properties of hydrogels. The mechanical properties are tested by dynamic mechanical analysis under both wet and dry condition. Porosities are tested by using micro-computed tomography and electron microscopy. The toxicity of hydrogels is analyzed by motor neuron survival and neuron growth.
The functional recovery behavior is tested by Basso Beactie and Breshahan test(BBB test) and Dynamic Weight Bearing test(DWB test). Histological analysis reveals the presence of neurons and new blood vessels, glial scar formation, inflammation and myelination. Finally, the degradable property of hydrogels is analyzed by measurement of mass loss (30) .
Cell-based strategies and molecule-based strategies
Hydrogels support injured spinal cords as well as prevent scar formation by creating a hospital environment for tissue regeneration. 3-D structure pores and channels of hydrogels provide substrates for tissue ingrowth, combined with therapeutic cells and molecules (31) . Hydrogel-based treatment gives us hope to explore a desired effective strategy for SCI.
Cell-based strategies
Delivering therapeutic cells to lesion sites has always been one of the most widely regenerative strategies for decades. This method not only stimulates nerve regeneration and restores lost cells, but also provides trophic factors including anti-inflammatory and growth factors. These cell processes can modulate and promote recovery after SCI. Among these cell-based treatments, stem cell therapy seems to be a promising approach to regeneration. Experiments which combine human fetal neural stem cells and hydrogels has been explored. Human fetal neural stem cells (hNSCs) is a type of stem cell that can have multiple potential differentiation properties and is suitable for human transplantation. Jason R. Thonhoff et al. explored three kinds of hydrogels for delivery of hNSCs: Pluronic F-127, Matrigel and PuraMatrix. Among these hydrogels, PuraMatrix is proven to be the most optimal hydrogel for hNSCs (32) . Růžička J et al. combined hNSCs with serotonin-modified poly (2-hydroxyethyl methacrylate) hydrogel (pHEMA-5HT) and demonstrated that this kind of hydrogel provide a supportive environment to stimulate hNSCs differentiation both in vitro and vivo for regeneration (33) .
Adult neural stem/progenitor cells (NPCs) are promising grafted cells due to their ability to self-renew and to differentiate to oligodendrocytes, astrocytes and neurons. Andrea J et al. explored survival and efficacy of brain stem/progenitor cells injected to a subacute SCI model of rats combined with hyaluronan and methyl cellulose(HAMC) modified with rat platelet derived growth factor-A (rPDGF-A). This strategy demonstrated significant reduction in cavitation, improved survival of grafted cells and behavioral improvement, and increased differentiation of oligodendrocytic (34) .
Induced pluripotent stem cell-derived neural stem cell (iPSC-deviced NSCs) transplantation for treatment of SCI has shown therapeutic potential by differentiating into neurons and glia to stimulate new tissue across injury sites. Pre-clinical experiments demonstrated that transplantation of iPSC-deviced NSCs shows promising survival, differentiation and therapeutic effects (35) . Carla Christina Medalha et al. transplanted NPCs composed of neuro-restricted and glia-restricted progenitors to partial lesion models and showed great survival and ability to generate neurons. However, when transplanted to a complete transection model of rats, they found poor survival grafted cells using different kinds of matrices and lesion methods (36) . For regenerative medicine, recently it was found that rather than going through an IPSC stage, a nonviral deterministic transfection yields efficient reprogramming and ability to control complexity of induced neurons (37) .
Olfactory ensheathing cells (OECs) delivery is another promising treatment for SCI. OECs can obtain the ability of neurogenesis throughout their life in olfactory system. Zhang Ling-Ling et al. engineered a new peptide hydrogel scaffold named GRGDSPmx to provide cell growth guidance like natural ECM by mixing the pure RADA16 (AcN-RADARADARADARADA-CONH₂) and designer peptide RADA16-GRGDSP ( H-Gly-Arg-GlyAsp-Ser-Pro-OH) solution. Analyses showed increased proliferation and less apoptosis of OECs. Furthermore, GRGDSPmx provide desired environment for OECs (38) .
Schwann cells (SCs) transplantation is also a promising treatment strategy for SCI. It has been shown to reduce neurons' loss, stimulate neurons' regeneration and promote myelination. It is demonstrated that transplantation combining SCs with matrices can achieve long-term survival of SCs and promote grafted vascularization and axonal ingrowth. Matrigel and pure matrices have been applied to the delivery of SCs and promote survival of SCs and enhance locomotor improvement (39).
Molecule -based strategies
SCI is very complex; trophic factors play a crucial role in tissue regeneration. These trophic factors have functions of promoting angiogenesis, inhibiting scar formation, reducing inflammation, and, increasing NPCs survival. Delivery of these trophic factors holds great promise when combined with hydrogels to achieve local and sustained release.
Chondroitinase ABC (ChABC) is one of these trophic factors that degrade the glials and lead to the regrowth of neurons. The regrowth and tissue repair is caused by the degradation of chondroitin sulfate proteoglycans (CSPGs), which is a kind of axon growth inhibiting factor promoting glial scar formation. ChABC is thermally unstable, so it is difficult to deliver. Malgosia M et al. engineered an affinity-based modified methylcellulose(MC) hydrogel that achieves sustained release of bioactive ChABC. The MC hydrogel modified with an SH-3 bind peptide can control the release rate of ChABC by changing the binding stren- gth of SH3-protein/ SH3-peptide pair (40) .
Neurotrophin-3 is a trophic factor that modulates the survival and function of tyrosine kinase C-positive neurons. Jason C et al. achieved sustained and local release by encapsulating NT-3 in poly(lacticco-glycolic acid) (PLGA) dispersed in an injectable hydrogel of hyaluronan and methyl cellulose (HAMC) (41) . J Piantino et al. established a biodegradable injectable hydrogel that achieved long-term NT-3 release over 2 weeks. The hydrogel/NT-3 treated animals showed great axon growth and functional improvement (12) .
Delivering vascular endothelial growth factor (VEGF) to SCI has been explored as a promising therapeutic strategy. VEGF is a factor that has been applied to spinal cord regeneration by combining it with hydrogels and enhancing neural growth at and around the lesion site. Anne dex Rieux et al. demonstrated that local delivery of VEGF from injectable alginate: fibrinogen-based hydrogel supported angiogenesis and neural growth. Although no functional recovery was observed, fibrinogen-based hydrogel is well tolerated by spinal cord tissue (42) .
Glial cell-line-derived neurotrophic factor (GDNF) is a promising strategy because GDNF promotes survival and growth of dopaminergic, motor, peripheral sensory, and neurons. It is demonstrated that GDNF has neuroprotective effects which lead to tissue and axonal regeneration. Eduardo et, engineered a delivery system by encapsulating GDNF in microspheres and releasing it from an injectable alginate hydrogel. This kind of delivery system showed support to spinal cord plasticity and functional recovery (43) . Deniece Fon et al. demonstrated that GDNF-loaded injectable Gelatin-based hydrogel can attract NPCs migration from the subventricular zone (SVZ) and support NPCs survival while reducing reactive gliosis (44) .
Nogo-A is a myelin-associated inhibitor that can reduce neurite growth by creating an inhospitable regeneration environment at the lesion site. Nogo-A can also bind to Nogo-66 receptors (NgR) to mediate the inhibition of axonal regeneration (45) . Yue-Teng Wei et al. combined hyaluronic acid (HA) based hydrogel modified with poly-L-lysine (PLL) and Nogo-66 receptor antibody (antiNgR) and then delivered the HA PLL/antiNgR to the hemisection spinal cord model of rats. Eight weeks after transplantation, the method showed significant support in angiogenesis and helped the reduction of glial formation (46) . Anti-NogoA has been shown to improve functional recovery and it is an IgG that can not cross BBB and BCS-FB. Jason C et al. engineered a delivery system composed of anti-NogoA-loaded poly(lactic-co-glycolic acid) nanoparticles dispersed in a hydrogel of hyaluronan (composite HAMC). Co-capsulated with MgCO 3 and CaCO 3 , this achieved a long-term release of anti-NogoA and improved the bioactivity of anti-NogoA (47).
Dafin F et al. demonstrated that delivery of growth hormones protected neurons after SCI (48) . gel is a promising delivery system for sustained and local release of bFGF to the injured spinal cord and this study provides a potential therapy for SCI (50) .
In conclusion, remarkble improvements have been made combining hydrogel-based delivery system with trophic factors and systemic administration of these molecules is limited due to BCSFB. Hydrogel-based local delivery can bypass this barrier to increase the efficiency of therapy without damaging bioactivity of these molecules. Sustained release can be achieved by encapsulation of molecules into nanoparticles or microspheres.
Conclusion
SCI is a complex disease that has challenging obstacles yet to be overcome. Systemic administration is hampered by BBB and BCSFB, which lead to therapeutic failure. However, great progress has been made in the field of tissue engineering and regenerative medicine due to the application of hydrogels which not only provide support for grafted cells, but also achieve a sustained and local release of trophic molecules which modulate cells' processes and inflammation, promote angiogenesis, and inhibit the formation of glial scars Unfortunately, there still remain challenges in cell-based and molecule-based delivery via hydrogels treatment strategies we need to face. It is demonstrated that the survival of grafted cells needs to be improved. Further modification of hydrogels are required to achieve long-term support of diffusion of implanted cells (51) . Cerebrospinal fluid flux is proven to play a crucial role in molecule delivery and influences hydrogel placing site (52) . In the future, combined strategies based on cells and molecules will be needed to improve outcomes of SCI regeneration, and more modifications will be required to achieve various demands of delivery system according to different conditions.
